These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28302060)

  • 1. Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants.
    Muñoz MA; Mundet-Tuduri X; Real J; Del Val JL; Domingo M; Vinyoles E; Calero E; Checa C; Soldevila-Bacardit N; Verdú-Rotellar JM
    BMC Fam Pract; 2017 Mar; 18(1):38. PubMed ID: 28302060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of survival and hospitalization in older, heart failure patients receiving home healthcare.
    Muñoz MA; Real J; Del Val JL; Vinyoles E; Mundet X; Frigola-Capell E; Llauger MA; Orfila F; Domingo M; Verdú-Rotellar JM
    Int J Cardiol; 2016 Mar; 207():145-9. PubMed ID: 26802820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.
    Poppe KK; Squire IB; Whalley GA; Køber L; McAlister FA; McMurray JJ; Pocock S; Earle NJ; Berry C; Doughty RN;
    Eur J Heart Fail; 2013 Nov; 15(11):1220-7. PubMed ID: 23803952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.
    Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
    Scand J Prim Health Care; 2018 Jun; 36(2):207-215. PubMed ID: 29633886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital mortality and prognostic factors in patients admitted for new-onset heart failure with preserved or reduced ejection fraction: a prospective observational study.
    Tribouilloy C; Rusinaru D; Leborgne L; Mahjoub H; Szymanski C; Houpe D; Béguin M; Peltier M
    Arch Cardiovasc Dis; 2008 Apr; 101(4):226-34. PubMed ID: 18654097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline.
    Smith GL; Masoudi FA; Vaccarino V; Radford MJ; Krumholz HM
    J Am Coll Cardiol; 2003 May; 41(9):1510-8. PubMed ID: 12742291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
    Komajda M; Carson PE; Hetzel S; McKelvie R; McMurray J; Ptaszynska A; Zile MR; Demets D; Massie BM
    Circ Heart Fail; 2011 Jan; 4(1):27-35. PubMed ID: 21068341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction.
    Kapoor JR; Kapoor R; Ju C; Heidenreich PA; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 Jun; 4(6):464-72. PubMed ID: 27256749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study.
    Verdú-Rotellar JM; Frigola-Capell E; Alvarez-Pérez R; da Silva D; Enjuanes C; Domingo M; Mena A; Muñoz MA
    Eur J Gen Pract; 2017 Dec; 23(1):107-113. PubMed ID: 28376668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term and clinical profile of heart failure with recovered ejection fraction in a non-tertiary hospital.
    Martínez-Mateo V; Fernández-Anguita M; Cejudo L; Martín-Barrios E; Paule AJ
    Med Clin (Barc); 2019 Jan; 152(2):50-54. PubMed ID: 29884453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting hospitalization and mortality in a retrospective study of elderly patients with heart failure.
    Björklund J; Pettersson L; Agvall B
    BMC Cardiovasc Disord; 2024 Apr; 24(1):227. PubMed ID: 38671397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.